Over a 3 y period, a total of 102 blood samples from 40 patients were longitudinally collected including 35 women with estrogen receptor-positive metastatic tumors and five with estrogen receptor status that was negative or unknown (See SI Appendix, Table S5 for demographic information). Here, ESR1 is linked to metastatic neoplasm.